Levomefolic acid (INN) is the metabolite of folic acid (Vitamin B9) and it is a predominant active form of folate found in foods and in the blood circulation, accounting for 98% of folates in human plasma [A19276]. It is transported across the membranes including the blood-brain barrier into various tissues where it plays an essential role in the DNA synthesis, cysteine cycle and regulation of homocysteine, where it methylates homocysteine and forms methionine and tetrahydrofolate (THF). Levomefolate is approved as a food additive and is designated a GRAS (generally regarded as safe) compound [L773]. It is available commercially as a crystalline form of the calcium salt (Metafolin(R)), which has the stability required for use as a supplement [A19276]. Supplementation of levomefolic acid is desired over folic acid due to reduced potential for masking vitamin B12 deficiency symptoms.
Levomefolate Calcium, Pyridoxal 5-phosphate, Methylcobalamin and Schizochytrium DHA Oil
TriStart DHA
Davimet-M
Safyral
Chromagen
Virt-PN Plus
Vitafol Nano
L-Methyl-MC
Enl
Floriva
PramLyte
Select-OB Plus DHA Prenatal Supplement Plus DHA
Tricare Prenatal 2-part Daily Prenatal Vitamin System
Biopar delta-FORTE
Drospirenone, Ethinyl Estradiol and Levomefolate Calcium and Levomefolate Calcium
Zatean-Pn DHA
Virt-PN
Puralor
Poly-VI-flor
Tendera-OB
Obstetrix ONE
L-Methyl MC
Virt-Pn DHA
Levomefolate Calcium, Cyanocobalamin and Pyridoxine Hydrochloride
Tydemy
NuFera
Multi-Vit-Flor
L-Methyl MC NAC
Poly-Vi-Flor
EnLyte
Virt-PN DHA
Hemax
L-Methyl-B6-B12
Multivitamin with Fluoride
L-Methyl PNV DHA
Levomefolate Calcium and Algal
Zatean-Pn
EnBrace HR
Prenate Mini
Niferex
Obstetrix EC
L-Methyl-MC-NAC
Prenate Pixie
Beyaz
KeyFolic
Levomefolate Calcium and Schizochytrium DHA
Livita Children
Indication
For the treatment and prevention of folate deficiency and for use as an antidote against folic acid antagonists. Contained in oral contraceptives to reduce the risk of neural tube defects arising from folic acid deficiency for pregnant women who conceived during use or shortly after the discontinuation of the product. Being studied for use as a treatment for cardiovascular diseases [A19273] and adjunct therapy for patients undergoing antidepressant pharmacotherapy [A19271, A19272].
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682